- Hindi news
- National
- Bill Gates on India Coronavirus Vaccine Production | Here's the latest news updates from Bill Gates Microsoft Founder
new Delhi13 minutes ago
- Copy link
Bill Gates said that once the vaccine is ready, the entire world will be eyeing India for its production on a large scale. (File photo)
- There is a possibility of vaccine coming in 2021, then we will need to produce it on a large scale: Gates
- Foundation working with Serum Institute to increase vaccine production and delivery
The world's wealthiest person and Microsoft co-founder Bill Gates has called Corona the biggest event since World War. He said on Tuesday that India's will to produce the Corona vaccine and the ability to supply it to developed countries will play a key role in preventing the epidemic in the world.
In an interview with the news agency, Gates said that once the vaccine is ready, the entire world will be eyeing India for its production on a large scale.
Expected to get vaccine by next year
He said that we all want that a safe and effective vaccine should be prepared in India at the earliest. Only then will our plan come into focus. He hoped that the vaccine could come next year i.e. 2021. Then we will need to produce it on a large scale. The world is looking towards India to make it available to other developing countries as well. However, what would be the way to deliver it would have to be decided.
Hands mixed with Serum Institute
The Bill & Milinda Gates Foundation, one of the world's largest charities, is playing an important role in the fight against Corona in the world. The Foundation has joined hands with the Serum Institute in India. Its goal is to increase production and delivery of the corona vaccine.
“Those who need more, the vaccine will reach India with the help of
He said that India will help in deciding that we are all equal. We have a model that shows that the vaccine is for those who need it most. This will save half the life. If you send it only to rich countries, you will lose many lives.
Discussing with NITI Aayog as well
In a telephonic interview, he said that we are considering production of the vaccine in India, whether it comes from AstraZeneca, Oxford or Novavax or Johnson & Johnson. We have publicly spoken about the arrangement where the serum would be able to make large amounts of AstraZeneca and Novavax vaccines.
He said that this is being discussed with Bio-E and the Johnson & Johnson vaccine. Our Foundation is also in discussion with the NITI Aayog of India.
0
.
